GH Research
(NASDAQ) GHRS
GH Research Financials at a Glance
Market Cap
$1.67B
Revenue (TTM)
$0.00
Net Income (TTM)
-$56.41M
EPS (TTM)
-$0.91
P/E Ratio
-26.86
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$23.27
Volume
282,683
Open
$24.35
Price
$23.27
Volume
282,683
Open
$24.35
Previous Close
$23.25
Daily Range
$23.08 - $25.31
52-Week Range
$11.32 - $25.94
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$23.27
Volume
282,683
Open
$24.35
Previous Close
$23.25
Daily Range
$23.08 - $25.31
52-Week Range
$11.32 - $25.94
Estimated Earnings Date
Aug 6, 2026
GHRS News
GHRS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GH Research
Industry
Pharmaceuticals
Sector
Health CareEmployees
73
CEO
Villy Valcheva, MD
Website
www.ghres.comHeadquarters
Dublin, D02 NX43, IE
GHRS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-20%
Return on Capital
-25%
Return on Assets
-20%
Earnings Yield
-3.72%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.67B
Shares Outstanding
68.56M
Volume
282.68K
Avg. Volume
236.47K
Financials (TTM)
Gross Profit
-$335.00K
Operating Income
-$60.68M
EBITDA
-$60.34M
Operating Cash Flow
-$43.55M
Capital Expenditure
-$121.00K
Free Cash Flow
-$43.67M
Cash & ST Invst.
$280.71M
Total Debt
$512.00K
GH Research Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$91.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.67B
N/A
Market Cap/Employee
$33.50M
N/A
Employees
50
N/A
Net Income
-$18.97M
-75.4%
EBITDA
-$18.66M
-73.9%
Quarterly Fundamentals
Net Cash
$266.89M
-8.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$75.00K
-76.7%
Short Term Debt
$357.00K
+6.3%
Return on Assets
-20.49%
N/A
Return on Invested Capital
-25.31%
N/A
Free Cash Flow
-$10.73M
-25.1%
Operating Cash Flow
-$10.67M
-24.4%